You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Esophagogastric Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagogastric Cancer, HER2-Negative Trial in United States (regorafenib, nivolumab, FOLFOX chemo with oxaliplatin)

Active, not recruiting
  • Esophagogastric Cancer
  • HER2-Negative
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2022

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Gastric Cancer Trial in Frankfurt am Main (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Feb 21, 2022

Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

Not yet recruiting
  • Gastric or Esophagogastric Junction Adenocarcinoma
  • nimotuzumab plus paclitaxel
  • placebo plus paclitaxel
  • (no location specified)
Aug 3, 2023

Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric

Completed
  • Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
  • +5 more
  • S-1 de-escalation
  • Chemotherapy by Investigator's choice
  • Heidelberg, Baden-Württemberg, Germany
    NCT-Med. Onkologie
Mar 25, 2021

Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • Sacituzumab govitecan
  • (no location specified)
Nov 9, 2023

Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

Recruiting
  • Gastric Carcinoma Stage IV
  • Esophagogastric Junction Adenocarcinoma Stage IV
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 11, 2021

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +22 more
Aug 16, 2022

Gastric Cancer, Esophageal Cancer, Adenocarcinoma Gastric Trial in Germany (Nivolumab, Ipilimumab)

Completed
  • Gastric Cancer
  • +5 more
  • Amberg, Germany
  • +34 more
May 17, 2022

Esophageal Cancer, Gastric Cancer Trial in United States (pembrolizumab, trastuzumab, capecitabine)

Active, not recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Basking Ridge, New Jersey
  • +7 more
Sep 17, 2021

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • (no location specified)
Aug 18, 2022

Epiphora Due to Insufficient Drainage, Left Side, Epiphora Due to Insufficient Drainage, Right Side Trial in Tianjin

Recruiting
  • Epiphora Due to Insufficient Drainage, Left Side
  • Epiphora Due to Insufficient Drainage, Right Side
  • Esophagogastric Side to Side Anastomosis
  • Esophagogastric End to Side Anastomosis
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Apr 2, 2023

Esophagogastric Cancer Trial in United States (Amivantamab)

Recruiting
  • Esophagogastric Cancer
  • Boston, Massachusetts
  • +7 more
Oct 24, 2022

Esophagogastric Cancer Trial in New York (Survey, Intra-oral camera)

Recruiting
  • Esophagogastric Cancer
  • Survey
  • Intra-oral camera
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Dec 28, 2022

Esophageal Cancer, Gastric Cancer Trial in United States (Regorafenib, 5-Fluorouracil, Leucovorin)

Completed
Has Results
  • Esophageal Cancer
  • Gastric Cancer
  • Basking Ridge, New Jersey
  • +4 more
May 1, 2020

Esophagogastric Cancer Trial in Toronto (PET-MRI)

Recruiting
  • Esophagogastric Cancer
  • PET-MRI
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 5, 2023

Proximal Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Reflux Disease Trial in Nanchong (Proximal Gastrectomy

Recruiting
  • Proximal Gastric Adenocarcinoma
  • +2 more
  • Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
  • Nanchong, Sichuan, China
    Yunhong Tian
Aug 23, 2022

Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation Trial in United States (Pembrolizumab, Trastuzumab)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Baltimore, Maryland
  • +8 more
Nov 3, 2023

Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

Recruiting
  • Gastric Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
  • +7 more
Jan 31, 2022

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

Recruiting
  • Esophagus Cancer
  • +5 more
  • Radiotherapy
  • +5 more
  • Anyang, Henan, China
  • +4 more
Aug 17, 2022

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
May 5, 2022

Gastric Cancer, Esophagogastric Junction Disorder Trial in Beijing (Savolitinib)

Recruiting
  • Gastric Cancer
  • Esophagogastric Junction Disorder
  • Beijing, Beijing, China
    Beijing Cancer Hopspital
Aug 30, 2021

Novel Staging Schemes for Siewert Type II Esophagogastric

Completed
  • Adenocarcinoma of the Esophagogastric Junction
  • esophagogastric junction cancer surgery
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Nov 1, 2022

Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

Active, not recruiting
  • Stomach Neoplasms
  • Shanghai, China
    Renji Hospital
Apr 3, 2023

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

Recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Duarte, California
  • +33 more
Aug 23, 2022